Wed, June 5, 2024

Raghuram Selvaraju Reiterated (SPRB) at Hold on, Jun 5th, 2024

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Spruce Biosciences, Inc." (SPRB) at Hold on, Jun 5th, 2024.

Raghuram has made no other calls on SPRB in the last 4 months.



There are 5 other peers that have a rating on SPRB. Out of the 5 peers that are also analyzing SPRB, 4 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Aydin Huseynov of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Thursday, March 14th, 2024
  • Evan Wang of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, March 14th, 2024
  • Gregory Renza of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 14th, 2024
  • Joseph Schwartz of "Leerink Partners" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 14th, 2024


This is the rating of the analyst that currently disagrees with Raghuram


  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $3 on, Thursday, March 14th, 2024